Executive record
Geoffrey Parker
Most recent record: Allogene Therapeutics, Inc. discloses CFO departure: Geoffrey Parker (named as the outgoing officer), effective November 6, 2026.
2 verified records · 1 company
Career line from the records
2Each seat as a filing states it, newest first. Titles appear only as the filing prints them for this person.
2026-09-02DepartureAllogene Therapeutics, Inc.
Allogene Therapeutics, Inc. discloses CFO departure: Geoffrey ParkerNamed as the outgoing officer
effective November 6, 2026 · 8-K filed September 2, 2026 · sec.gov, Item 5.02
2026-03-1210-K signatureAllogene Therapeutics, Inc.
Signed the annual report as Chief Financial Officer ( Principal Financial Officer )
10-K filed March 12, 2026 · sec.gov
Companies
1This page lists only verified filing records that name Geoffrey Parker, matched by the name as the filings print it; it is not a career history. Corrections: the corrections page.